腸管スピロヘータ症(human intestinal spirochetosis;HIS)の臨床的意義についての検討

智子 梅田, 宏 芹澤, 拓 小林, 貴彦 豊永, 詠子 齊藤, 雅嗣 中野, 肇 樋口, 令 常松, 憲明 渡邊, 紀文 日比, 森永 正二郎
{"title":"腸管スピロヘータ症(human intestinal spirochetosis;HIS)の臨床的意義についての検討","authors":"智子 梅田, 宏 芹澤, 拓 小林, 貴彦 豊永, 詠子 齊藤, 雅嗣 中野, 肇 樋口, 令 常松, 憲明 渡邊, 紀文 日比, 森永 正二郎","doi":"10.11405/NISSHOSHI.114.230","DOIUrl":null,"url":null,"abstract":": The clinical and pathological features of human intestinal spirochetosis (HIS) are not well known. Here we report 55 patients with HIS who were diagnosed at our institution during the past 5 years. Seven patients presented with symptoms such as abdominal pain or diarrhea, while the others were incidentally diagnosed during screening colonoscopy. Most patients had non-specific endoscopic findings, including intestinal edema or erosion. The diagnosis of HIS was histologically confirmed via hematoxylin and eosin staining, periodic acid-Schiff staining, and/or immunohistochemistry using anti-Treponema pallidum antibody. Among the 55 patients, five were diagnosed with diseases other than HIS (amoebic colitis, three;ulcerative colitis, one). Sixteen patients were treated with either amoxicillin or metronidazole;only metronidazole proved to be effective. The clinical significance of asymptomatic HIS remains unknown. Some case reports suggest a risk for increased severity in patients with immunodeficiency and/or sexually transmitted diseases. Therefore, aggressive treatment for HIS should be considered, particularly in high-risk patients.","PeriodicalId":341053,"journal":{"name":"The Japanese journal of gastro-enterology","volume":"452 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2017-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Japanese journal of gastro-enterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11405/NISSHOSHI.114.230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

: The clinical and pathological features of human intestinal spirochetosis (HIS) are not well known. Here we report 55 patients with HIS who were diagnosed at our institution during the past 5 years. Seven patients presented with symptoms such as abdominal pain or diarrhea, while the others were incidentally diagnosed during screening colonoscopy. Most patients had non-specific endoscopic findings, including intestinal edema or erosion. The diagnosis of HIS was histologically confirmed via hematoxylin and eosin staining, periodic acid-Schiff staining, and/or immunohistochemistry using anti-Treponema pallidum antibody. Among the 55 patients, five were diagnosed with diseases other than HIS (amoebic colitis, three;ulcerative colitis, one). Sixteen patients were treated with either amoxicillin or metronidazole;only metronidazole proved to be effective. The clinical significance of asymptomatic HIS remains unknown. Some case reports suggest a risk for increased severity in patients with immunodeficiency and/or sexually transmitted diseases. Therefore, aggressive treatment for HIS should be considered, particularly in high-risk patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肠螺旋体症(human intestinal spirochetosis;HIS)临床意义的探讨
人类肠道螺旋体病(HIS)的临床和病理特点尚不清楚。在此,我们报告了过去5年中在我院诊断的55例HIS患者。7名患者出现腹痛或腹泻等症状,其余患者是在结肠镜检查时偶然诊断出来的。大多数患者有非特异性的内镜检查结果,包括肠水肿或糜烂。通过苏木精和伊红染色、周期性酸希夫染色和/或抗梅毒螺旋体抗体免疫组化,组织学上证实了HIS的诊断。55例患者中,5例被诊断为HIS以外的疾病(阿米巴结肠炎3例,溃疡性结肠炎1例)。16例患者用阿莫西林或甲硝唑治疗,只有甲硝唑证明有效。无症状HIS的临床意义尚不清楚。一些病例报告表明,免疫缺陷和/或性传播疾病患者的严重程度有增加的风险。因此,应考虑对HIS进行积极治疗,特别是对高危患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
腸管スピロヘータ症(human intestinal spirochetosis;HIS)の臨床的意義についての検討 内視鏡的粘膜下層剥離術(endoscopic submucosal dissection)の1年10カ月後に異時性肝転移をきたした胃神経内分泌癌(neuroendocrine carcinoma)の1例 Trousseau症候群として発症した腸間膜への播種をともなった胃mucosa-associated lymphoid tissue(MALT)リンパ腫の1症例 Helicobacter pylori未感染の胃粘膜に生じた0-IIa+IIc型分化型癌の1例 Low-dose FP療法が奏効した切除不能混合型肝癌の1例
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1